May 2025 | Blood Cancers Today

May 2025

This issue of Blood Cancers Today includes a feature on diet and multiple myeloma risk, a Get to Know with Kerry Rogers, MD, meeting news from AACR 2025, and more.

Features

In Focus

Nutritional Epidemiology in Blood Cancers: Science or Speculation?

Get to Know

Get to Know...Kerry Rogers, MD

GME Spotlight

Grand Rounds

Leukemia Fellow Highlights Modest Gains With Azacitidine-Venetoclax in HR-MDS Patients

Emerging Experts

MD Anderson Fellow Dives Deep into the Unknowns of FLT3-TKD-Mutated AML

News

Regulatory Actions

FDA Clears Way for Phase 3 Trial of Linperlisib in Advanced Peripheral T-Cell Lymphoma

Novel CLEVER-1-Targeting Immunotherapy Agent Holds FDA Orphan Drug Designation for MDS, AML

Bexobrutideg Receives FDA Orphan Drug Designation for Waldenström Macroglobulinemia

News Roundup

FDA Barred from Regulating Laboratory-Developed Tests After Industry Lawsuit

Unpacking the COA Prescription for Health Care Reform: What Does it Mean for Patients and Oncologists?

Meeting News

CD47, CD20-Targeting Bispecific Fusion Protein Evaluated for Refractory NHL in First-in-Human Trial

Clinical Study Finds Continuous Lenalidomide Delivery Effective and Well Tolerated in RRMM

ISB 2001 Yields New Prospects as Multiple Myeloma Treatment

MicroRNA-Based Therapy Shows Promising Molecular Activity in AML

Editor's Picks

Tumor Size, Radiotherapy Have Relapse Implications After Chemotherapy for Hodgkin Lymphoma

Which Pediatric cHL Patients Should Receive Transplant-Free Salvage Therapy?

BrECADD Recommended as Standard Treatment for Advanced-Stage, Classical Hodgkin Lymphoma After Promising PFS Results

HemOnc Happenings

ASPHO Recognizes Pediatric Hematologist-Oncologists at Annual Meeting

Frederick Locke, MD, Awarded Researcher of the Year by Moffitt Cancer Center

May 2025

Advertisement

Advertisement